Vectalys is the manufacturing platform of Flash Therapeutics. Vectalys is a CDMO providing custom & premade #lentiviral particles from R&D to GMP grade.
We are proud to announce that Vectalys has been awarded a Seal of Excellence certificate from the @EU_Commission as a result of its @EU_H2020 application. https://t.co/dxTr6XBImM
Come and meet us at #BIO2019 booth #2109. Pascale Bouillé (CEO) & JEAN-PIERRE SAINTOUIL (Business Development) will be glad to talk with you about your lentiviral vector projects. #genetherapy#SouthOfFranceAtBIO19@PoleEurobiomed https://t.co/uozrRnC8EF
Flash Therapeutics will be attending the BIO International Convention 2019, held June 3-6 in Philadelphia, PA. Come and meet our team booth #2109 (pavillon France). https://t.co/XaUwPDSc99 #BIO2019@Vectalys@PoleEurobiomed
Attending the 4th Annual Advances in Immuno-Oncology Congress in London? Visit us at booth #10 and don't miss our poster presentation about LentiFlash technology! #Immuno19#immunology#Immunotherapy @ImmunoOncConf
We’re happy to announce that we’ll be attending the 4th Annual Advances in Immuno-Oncology UK Congress held May 20 and 21, in London. We are looking forward to seeing you there! @OGConferences#biotech#Immunotherapy#immunotherapy2019 https://t.co/8xXj0r1OC4
Are you attending the #ASGCT19 ? Come and meet our team at booth #413! And don't miss our poster presentation about LentiFlash! (Tuesday Apr 30, 2019 5:00 PM - 6:00 PM) https://t.co/pymFBg8Kjc #GeneTherapy@Vectalys@ASGCTherapy
Flash Therapeutics recrute: Technicien(ne) administration des ventes. Pour en savoir plus et postuler, cliquez sur le lien suivant: https://t.co/nWV0owRv03 #biotech
@TWBredy @KateWassum@Kathorine@SvitlanaBach Very cool! Unfortunately dCas9 fusions won’t fit in an AAV, but we’ve found very strong effects with lentiviral vectors. And making these new tools inducible (with Dox, Cre, and light) is at the top of our list - stay tuned!
A woman from Oxford has become the first person in the world to have gene therapy to try to halt the most common form of blindness in the Western world. https://t.co/K7KKB6hMQm
#GMP grade #lentiviral vectors: Flash Therapeutics opens a GMP facility to produce lentiviral vector batches for customers conducting phase I/II #GeneTherapy clinical trials. Click on the following link to learn more: https://t.co/wDiCHJLVbH @Vectalys
L’Italien Luigi Naldini reçoit le Prix Jeantet-Collen - médecine translationnelle - pour son travail de pionnier en thérapie génique (développement d'un vecteur lentiviral dérivé du virus HIV) https://t.co/gFAmWS60bW via @LouisJeantetFDN
We are hiring! New positions are available to join the Flash Therapeutics’ team:
- Un(e) technicien(ne) administration des ventes
- Un(e) ingénieur(e) commercial(e)
To learn more about these offers click on the following link: https://t.co/WdTbLAKA3X #Biotech@Vectalys
Are you attending the @ESGCT 2018? Come and meet our team on site! Jean-Pierre Saintouil, business development manager and Regis Gayon, Vectorology & Cell Engineering Manager, will be delighted to welcome you at booth #8 https://t.co/n7EWimRIGI #GeneTherapy#biotech#ESGCT18